These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2503895)

  • 1. Bio-availability of three formulations of glibenclamide.
    Meyer BH; Müller FO; Luus HG; Eckert HG
    S Afr Med J; 1989 Aug; 76(4):146-7. PubMed ID: 2503895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of two oral formulations of glyburide (glibenclamide).
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
    Proc West Pharmacol Soc; 2007; 50():64-6. PubMed ID: 18605232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bio-availability of four formulations of furosemide.
    Meyer BH; Müller FO; Swart KJ; Luus HG; Werkman IM
    S Afr Med J; 1985 Oct; 68(9):645-7. PubMed ID: 3904040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacokinetics and pharmacodynamics of two commercial products containing glibenclamide.
    el-Sayed YM; Suleiman MS; Hasan MM; Abdel-Hamid ME; Najib NM; Sallam ES; Shubair MS
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):551-7. PubMed ID: 2515159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)].
    Haupt E; Putschky F; Zoltobrocki M; Schöffling K
    Dtsch Med Wochenschr; 1984 Feb; 109(6):210-3. PubMed ID: 6421561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of antacids on the bioavailability of glibenclamide.
    Zuccaro P; Pacifici R; Pichini S; Avico U; Federzoni G; Pini LA; Sternieri E
    Drugs Exp Clin Res; 1989; 15(4):165-9. PubMed ID: 2505996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems.
    Tashtoush BM; Al-Qashi ZS; Najib NM
    Drug Dev Ind Pharm; 2004 Jul; 30(6):601-7. PubMed ID: 15285333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes.
    Arnqvist HJ; Karlberg BE; Melander A
    Ann Clin Res; 1983; 15 Suppl 37():21-5. PubMed ID: 6433769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
    Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
    Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil).
    Ayanoglu G; Witte PU; Badian M
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):479-82. PubMed ID: 6414955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin bio-availability. A comparison of 4 products.
    Müller FO; Steyn JM; Hundt HK; Luus HG
    S Afr Med J; 1988 Dec; 74(11):566-7. PubMed ID: 3057655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.
    Uusitupa M; Södervik H; Silvasti M; Karttunen P
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):153-7. PubMed ID: 2110937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniform elimination pattern for glibenclamide in healthy Caucasian males.
    Spraul M; Streeck A; Nieradzik M; Berger M
    Arzneimittelforschung; 1989 Nov; 39(11):1449-50. PubMed ID: 2515863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N).
    Neugebauer G; Betzien G; Hrstka V; Kaufmann B; von Möllendorff E; Abshagen U
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):453-60. PubMed ID: 3932228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
    Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
    Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of glyburide in young and elderly nondiabetic adults.
    Schwinghammer TL; Antal EJ; Kubacka RT; Hackimer ME; Johnston JM
    Clin Pharm; 1991 Jul; 10(7):532-8. PubMed ID: 1907234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.